César Alejandro
Soutullo Esperón
Forscher bis um 2019
Summit Health Institute for Research and Education
Washington, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Summit Health Institute for Research and Education (4)
2018
-
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
CNS Drugs, Vol. 32, Núm. 5, pp. 455-467
-
Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: A descriptive analysis
BMC Psychiatry, Vol. 18, Núm. 1
2017
-
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
CNS Drugs, Vol. 31, Núm. 7, pp. 625-638
2014
-
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/ hyperactivity disorder in a randomized, Controlled trial
Neuropsychiatric Disease and Treatment, Vol. 10, pp. 2039-2047